DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
PF-00610355 is an investigational drug.
There have been 4 clinical trials for PF-00610355. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2008.
The most common disease conditions in clinical trials are Lung Diseases, Chronic Disease, and Lung Diseases, Obstructive. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for PF-00610355
|A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers||Pfizer||Phase 1|
|A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.||Pfizer||Phase 2|
|A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects||Pfizer||Phase 2|